ClinicalTrials.gg
Enrolling by invitationNCT07938359Updated Nov 16, 2026

Construction of a Safety-Oriented Strength Assessment System Using Digital Force Sensing and Artificial Intelligence Models

An observational study in Healthy Participant, sponsored by China Medical University Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 20 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by China Medical University Hospital · Observational

How we know

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
20 Years to 79 Years
Sex
All
01

Study summary

The goal of this observational study is to develop an intelligent exercise prescription estimation system that ensures both safety and accuracy in healthy middle-aged and older adults. The main question it aims to answer is:

Is it possible to estimate a dynamic 12RM by measuring the maximum voluntary isometric contraction (MVIC) using a digital force-sensing system combined with an AI model using a random forest algorithm? Participants will be tested of their (1) MVICs of three exercises and then (2) the dynamic 12RM tests of 6 free weight exercises.

Read the detailed description

The goal of this observational study is to develop an intelligent exercise prescription estimation system that ensures both safety and accuracy in healthy middle-aged and older adults. The main question it aims to answer is:

Is it possible to estimate a dynamic 12RM (repetition maximum) by measuring the maximum voluntary isometric contraction (MVIC) using a digital force-sensing system combined with an AI model using a random forest algorithm? Participants will be tested of their (1) MVICs of three exercises: bench press, seated row, and stand-up from squat; and then (2) the dynamic 12RM tests of 6 free weight exercises: bench press, overhead press, seated cable row, lat pulldown, barbell squat, and barbell deadlift.

02

Conditions studied

  • Healthy Participant

Keywords

  • Resistance Training
03

In context

Lead sponsor

China Medical University Hospital is the lead sponsor of 480 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Healthy participants aged from 20\~79 years old, who was confirmed their physical activity levels met the criteria for participation in resistance exercise.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Based on physical activity questionnaires, it was confirmed that the subjects' physical activity levels met the criteria for participation in exercise.

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular and metabolic disease risk based on ACSM exercise testing guidelines.
  • Conditions such as stroke sequelae, Parkinson's disease, spinal cord injury, or severe peripheral neuropathy causing significant limb tremors, impaired balance, or hemiplegia, assessed to potentially compromise signal acquisition accuracy.
  • History of lower-limb fracture or orthopedic surgery within the past six months.
  • Acute musculoskeletal pain or joint swelling on the day of testing, with a Visual Analog Scale (VAS) score greater than 5.
  • Severe degenerative arthritis resulting in significantly restricted joint range of motion, preventing the subject from maintaining the required testing positions.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy participants

    age from 20\~79

06

What researchers measure

Primary outcomes

  1. Static MVIC strength

    muscle strength (in kilogram) measuring during the 10-second Maximal Voluntary Isometric Contraction (MVIC) testing

    Time frame: Baseline

  2. Dynamic 12RM

    Dynamic twelve-repetition maximum (12RM) (in kilogram) of the muscle group

    Time frame: Baseline

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2026 (actual). Primary completion is estimated for Jul 2028, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2026
First posted
Nov 16, 2026
StartActual
Aug 1, 2026
Primary completionEst.
Jul 31, 2028
CompletionEst.
Oct 31, 2028
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07938359
Responsible party
Hsiu-Chen Lin (Professor, China Medical University Hospital) — Principal investigator
First posted
Nov 16, 2026
Start date
Aug 1, 2026
Primary completion
Jul 31, 2028 (estimated)
Completion
Oct 31, 2028 (estimated)
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion